NCT02209454View on ClinicalTrials.gov

Comparative Bioavailability of Dexketoprofen Trometamol Oral Solution vs Tablet Formulations

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

June 30, 2014

Conditions
Acute Pain
Interventions
DRUG

Enantyum® oral solution

One dose of 25 mg DKP oral solution

DRUG

Keral® tablet

One dose of 25 mg DKP tablet

Trial Locations (1)

CF48 4DR

Simbec Research Limited, Merthyr Tydfil

Sponsors

Lead Sponsor

Menarini Group
All Listed Sponsors
collaborator

Simbec Research

INDUSTRY

lead

Menarini Group

INDUSTRY

NCT02209454 - Comparative Bioavailability of Dexketoprofen Trometamol Oral Solution vs Tablet Formulations | Biotech Hunter | Biotech Hunter